7260 93 (Glyburide and Metformin Hydrochloride 1.25 mg / 250 mg)
Pill with imprint 7260 93 is Yellow, Elliptical / Oval and has been identified as Glyburide and Metformin Hydrochloride 1.25 mg / 250 mg. It is supplied by Teva Pharmaceuticals USA.
Glyburide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Glyburide/metformin 1.25 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 7260 93
Glyburide and Metformin Hydrochloride
- Imprint:
- 7260 93
- Strength:
- 1.25 mg / 250 mg
- Color:
- Yellow
- Size:
- 13.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Teva Pharmaceuticals USA
More about glyburide/metformin
- Glyburide/metformin Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 4 Reviews
- Drug class: antidiabetic combinations
- FDA Alerts (1)
Consumer resources
Other brands: Glucovance
Professional resources
- Glyburide and Metformin (FDA)
- Glyburide and Metformin Tablets (FDA)
- Glyburide and Metformin (Wolters Kluwer)
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
